Bacteria Combination

Product NDC

43742-1419

11-digit product format

437421419

Labeler code

43742

Product ID

43742-1419_26a539f0-eb80-475b-a45a-5d59629489ac

Type

HUMAN OTC DRUG

Nonproprietary name

Adenosinum Triphosphoricum Dinatrum, Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, Streptococcus Viridans, Pneumococcinum, Colibacillinum Cum Natrum Muriaticum, Echinacea (Angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (Mirabilis), Proteus (Vulgaris), Pseudomonas Aeruginosa, Yersinia Enterocolitica, Streptococcus Agalactiae, Legionella Pneumophila, Enterococcus Faecalis, Streptococcus Mutans, Listeria Monocytogenes, Dysentery Bacillus,

Dosage form

LIQUID

Route

ORAL

Labeler

Deseret Biologicals, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2019-06-03

Marketing end

2025-07-20

Substance

ADENOSINE PHOSPHATE DISODIUM; MALIC ACID; SODIUM DIETHYL OXALACETATE; OROTIC ACID; RIBOFLAVIN; APIOLE (PARSLEY); CINNAMIC ACID; STREPTOCOCCUS VIRIDANS GROUP; STREPTOCOCCUS PNEUMONIAE; ESCHERICHIA COLI; ECHINACEA ANGUSTIFOLIA; HELICOBACTER PYLORI; MYCOPLASMA PNEUMONIAE; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; YERSINIA ENTEROCOLITICA; STREPTOCOCCUS AGALACTIAE; LEGIONELLA PNEUMOPHILA; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS MUTANS; LISTERIA MONOCYTOGENES; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS; PROTEUS MORGANII; STREPTOCOCCUS EQUINUS

Active strength

6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record